Get started
Author

Nilesh Kapoor

Observed name: N. Kapoor
ORCID: 0000-0002-5674-619X
Observed ORCID: 0000-0002-5674-619X
OpenAlex ID: A5046972740
Overcoming Challenges in Recruitment of South Asians for Health Disparities Research in the USA
2017 · Arnab Mukherjea, Susan L. Ivey, et al. · Journal of Racial and Ethnic Health Disparities · 38
Colorectal Cancer Screening Among South Asians: Focus Group Findings on Attitudes, Knowledge, Barriers and Facilitators
2018 · Susan L. Ivey, Arnab Mukherjea, et al. · Journal of Health Care for the Poor and Underserved · 17
Incidence, description, and timing of serious and opportunistic infections in patients with hairy cell leukemia
2024 · Nilesh Kapoor, Qiuhong Zhao, et al. · eJHaem · 7
PDF
Metastatic Cutaneous Adnexal Carcinoma of the Head and Neck With Durable Response to an Aromatase Inhibitor Combined With a Cyclin‐Dependent Kinase 4/6 Inhibitor
2026 · Nilesh Kapoor, Manasa Narasimman, et al. · Head & Neck · 1
PDF
Successful use of trastuzumab deruxtecan in hepatic visceral crisis secondary to metastatic HER2-low breast cancer
2025 · Nilesh Kapoor, Malcolm Su, et al. · Current Problems in Cancer Case Reports · 1
An Incarcerated Individual With Weight Loss and Interstitial Pulmonary Infiltrates
2024 · Nilesh Kapoor, Christina Dietz, et al. · JAMA · 1
Incidence, Description, and Timing of Serious or Opportunistic Infections in Patients with Hairy Cell Leukemia Treated with Purine Nucleoside Analogues
2022 · Nilesh Kapoor, Qiuhong Zhao, et al. · Blood · 1
Effect of Radiation Therapy on Outcomes after CAR T-Cell Therapy for Non-Hodgkin Lymphoma
2022 · N. Kapoor, X. Mo, et al. · International Journal of Radiation Oncology*Biology*Physics · 1
ABCL-509 Healthcare Utilization and Costs in Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphoma
2022 · Nathan Denlinger, Ying Huang, et al. · Clinical Lymphoma Myeloma & Leukemia · 1
Long-term remission and survival in older adults with IDH-mutated acute myeloid leukemia treated with IDH inhibitors
2026 · Nilesh Kapoor, Fieke W. Hoff, et al. · Leukemia Research
Post-Transplant Outcomes in Older Patients with Newly Diagnosed Acute Myeloid Leukemia Treated with VEN/HMA vs 7+3: A Real-World, Multicenter Analysis From the MARROW Consortium
2026 · Nilesh Kapoor, Deedra Nicolet, et al. · Transplantation and Cellular Therapy
A multicenter real-world study on response and survival in older patients with acute myeloid leukemia treated with intensive chemotherapy versus VEN/HMA by 2022 and 2024 ELN risk stratifications: An analysis from the MARROW consortium
2025 · Nilesh Kapoor, Deedra Nicolet, et al. · Blood
PDF
Should “Medically Fit” Older Patients with Acute Myeloid Leukemia (AML) Continue to Receive Intensive Chemotherapy in the Venetoclax (VEN) Era?
2024 · Nilesh Kapoor, Ang Gao, et al. · Blood
AML-728 Clinical, Molecular, and Treatment Characteristics of Long-Term Survivors Amongst Older Adults with IDH1/2-Mutated Acute Myeloid Leukemia Treated with IDH Inhibitors
2024 · Nilesh Kapoor, Fieke Hoff, et al. · Clinical Lymphoma Myeloma & Leukemia
Clinical, Molecular, and Treatment Characteristics of Long-Term Survivors Amongst Older Adults with IDH1/2-Mutated Acute Myeloid Leukemia Treated with IDH Inhibitors
2024 · Nilesh Kapoor, Fieke Hoff, et al. · Clinical Lymphoma Myeloma & Leukemia
Outcomes of Autologous Transplant, Allogeneic Transplant, and Car T Cell Therapy in Tp53 Altered Mantle Cell Lymphoma: a Multi‐institution Retrospective Analysis
2023 · M. Messmer, A. Stack, et al. · Hematological Oncology
PDF
Retrospective Analysis of Residual Hairy Cell Leukemia Measured By IHC or Flow Cytometry and Frontline Treatment with Pentostatin on Time to Next Treatment
2022 · Andrew Stiff, Qiuhong Zhao, et al. · Blood
Poster: ABCL-509 Healthcare Utilization and Costs in Chimeric Antigen Receptor T-Cell Therapy for B-cell Lymphoma
2022 · Nathan Denlinger, Ying Huang, et al. · Clinical Lymphoma Myeloma & Leukemia
Works count: 18
Citation count: 68
H-index: 3
I10-index: 2
Year
Topic
Type